Soft Tissue Sarcoma Knowledge Centre
Management
Novel Therapy - Trabectedin
Clinical Updates
Designed for medical and health professionals to help them keep up to date onto the latest news about Yondelis® (trabectedin) efficacy against STS. The contents also include regular reports on outbreaks of the disease’s and its treatment.
The most recent clinical updates are listed below:
Abstract & Poster Selection of 2008 Annual Meetings
ASCO
The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology.
ACCR
The American Association for Cancer Research
ESSO
The European Society of Surgical Oncology, ESSO, was established in 1981 to advance the art, science and practice of surgery for the treatment of cancer. By arranging scientific conferences, professional exchanges and courses, ESSO endeavours to ensure that the highest possible standard of surgical treatment is available to cancer patients throughout Europe.
ESMO
The European Society for Medical Oncology (ESMO) is the leading European professional medical oncology organization comprising a network of more than 5,000 oncology professionals in over 100 countries.
AACR-NCI-EORTC
The AACR can assist journal authors in meeting their funders' archiving mandates. Authors of articles published in AACR journals, who are required by their funders to archive their papers, can elect to have the AACR deposit their accepted manuscripts to PubMed Central or UK PubMed Central, thereby meeting the requirements of the following funding agencies: National Institutes of Health; Howard Hughes Medical Institute; Cancer Research UK; Welcome Trust; and the Medical Research Council.
View the European Journal of Cancer
CTOS
The Connective Tissue Oncology Society was formed in 1995 and incorporated in 1997. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is to advance the care of patients with connective tissue tumors and to increase knowledge of all aspects of the biology of these tumors, including basic and clinical research.
View the CTOS 15th Annual Meeting details
Summary of Product Characteristics (SmPC)
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk. Adverse events should also be reported to Pharma Mar (contact details below).
Adverse Events Reporting
Pharmacovigilance Department
- Fax: +34 91 846 6004
- Tel: +34 91 846 6055
- e-mail: phv@pharmamar.com